Autoliv Receives 2025 Automotive News PACE Pilot Recognition

Autoliv Receives 2025 Automotive News PACE Pilot Recognition

STOCKHOLM, April 16, 2025 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), was named a 2025 Automotive News PACE Pilot Innovation to Watch at the awards ceremony on April 15, 2025, in Michigan, US. The recognition acknowledges post-pilot,...

Ample Transfers Receives In-Principle Approval from MAS to Expand Regulated Payment Services in Singapore

Ample Transfers Receives In-Principle Approval from MAS to Expand Regulated Payment Services in Singapore

Ample Transfers plans to broaden digital payment capabilities following in-principle approval from the Monetary Authority of Singapore. SINGAPORE, April 14, 2025 /PRNewswire/ -- Ample Transfers, a Singapore-based provider of remittance and...

Ramki Sankaranarayanan Receives EGA's Hermes Lifetime Achievement Award for Pioneering Innovation in Global Content Operations

Ramki Sankaranarayanan Receives EGA's Hermes Lifetime Achievement Award for Pioneering Innovation in Global Content Operations

LOS ANGELES, April 5, 2025 /PRNewswire/ -- The Entertainment Globalization Association (EGA) has honored Ramki Sankaranarayanan, Founder and Global CEO of Prime Focus Technologies (PFT), with the 2025 Hermes Lifetime Achievement Award. The accolade...

ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach

ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach

JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA)...

VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA

VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA

SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization technology specialist focused on hydrogen fuel cells and supporting systems, has received Type Approval from RINA, the Italian classification society, for its...

Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia

Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia

SHANGHAI, March 17, 2025 /PRNewswire/ -- Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA) for RN0361-an APOC3 targeted...

Korea Ginseng Corp. (JungKwanJang) Receives 'Tyler Award' from American Botanical Council

Korea Ginseng Corp. (JungKwanJang) Receives 'Tyler Award' from American Botanical Council

- The American Botanical Council (ABC) selects institutions that contribute to scientific research on natural products worldwide. CERRITOS, Calif., March 11, 2025 /PRNewswire/ -- Korea Ginseng Corp. (KGC), known for its flagship brand JungKwanJang,...

mF International Limited Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

mF International Limited Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

HONG KONG, Feb. 4, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), a Hong Kong-based experienced financial trading solutions provider, today announced that it has received an extension of 180...

Axonify Receives Gold and Silver in Brandon Hall Group's 2024 Excellence in Technology Awards

Axonify Receives Gold and Silver in Brandon Hall Group's 2024 Excellence in Technology Awards

Recognized with Gold Award for "Best Advance in Learning Management Measurement/Business Impact Tools," Silver Award for "Best Advance in a Generative AI Solution" WATERLOO, ON, Jan. 7, 2025 /PRNewswire/ -- Axonify, a global leader in frontline...

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding...

  • 1
  • 2
  • menu
    menu